MERIDOL PERIO CHX

MERIDOL PERIO CHX

Marketed by: GABA GmbH
Active ingredient: Chlorhexidini digluconas
Other information: oromucosal solution - 2 mg/ml

Available in: Finland
Language: English
Source: Fimea

MINOTEK

MINOTEK

Marketed by: OraPharma Europe Inc
Active ingredient: Minocyclini hydrochloridum
Other information: periodontal powder - 1 mg

Available in: Finland
Language: English
Source: Fimea

MILK OF MAGNESIA

MILK OF MAGNESIA

Marketed by: Sanofi-Winthrop Production Division
Active ingredient: Magnesii hydroxidum
Other information: oral liquid - 85 mg/ml

Available in: Finland
Language: English
Source: Fimea

MAGNESIAMAITO

MAGNESIAMAITO

Marketed by: Orion Oyj
Active ingredient: Magnesii hydroxidum pasta
Other information: oral suspension - 82.5 mg/ml

Available in: Finland
Language: English
Source: Fimea

MEDISAN

MEDISAN

Marketed by: Schering Oy
Active ingredient: Aluminii hydroxidum-magnesii carbonas gel.
Other information: chewable tablet

Available in: Finland
Language: English
Source: Fimea

MUCAINE

MUCAINE

Marketed by: John Wyeth & Brother Ltd
Active ingredient: Oxetacainum,Magnesii oxidum leve,Aluminii oxidum
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: Aktiebolaget Draco
Active ingredient: Silicii dioxidum,Dimeticonum 1000
Other information: capsule - 100 mg

Available in: Finland
Language: English
Source: Fimea

MEDISAN FORTE

MEDISAN FORTE

Marketed by: Schering Oy
Active ingredient: Aluminii hydroxidum carbonas-magnesii hydroxidum su
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: Aktiebolaget Draco
Active ingredient: Silicii dioxidum,Dimeticonum 1000
Other information: drops - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: Tika Läkemedel Ab
Active ingredient: Dimeticonum 1000,Silica colloidalis anhydrica
Other information: capsule - 100 mg

Available in: Finland
Language: English
Source: Fimea

MAGARAL

MAGARAL

Marketed by: Orion Oyj
Active ingredient: Magaldratum
Other information: chewable tablet - 400 mg

Available in: Finland
Language: English
Source: Fimea

MAGARAL

MAGARAL

Marketed by: Orion Oyj
Active ingredient: Magaldratum
Other information: chewable tablet - 800 mg

Available in: Finland
Language: English
Source: Fimea

MAGARAL

MAGARAL

Marketed by: Orion Oyj
Active ingredient: Magaldratum
Other information: oral liquid - 160 mg/ml

Available in: Finland
Language: English
Source: Fimea

MAGARAL MINTTU

MAGARAL MINTTU

Marketed by: Orion Oyj
Active ingredient: Magaldratum
Other information: oral liquid - 160 mg/ml

Available in: Finland
Language: English
Source: Fimea

MYLANTA

MYLANTA

Marketed by: Parke Davis & Co. Ltd.
Active ingredient: Magnesii hydroxidum,Aluminii hydroxidum gel. siccatum,Methylpolysiloxan
Other information: tablet

Available in: Finland
Language: English
Source: Fimea

MYLANTA

MYLANTA

Marketed by: Parke Davis & Co. Ltd.
Active ingredient: Aluminii hydroxidum gel. siccatum,Magnesii hydroxidum 30%,Antifoam m 30 emulsion
Other information: oral liquid

Available in: Finland
Language: English
Source: Fimea

MELUSTON

MELUSTON

Marketed by: Aventis Pharma Deutschland GmbH
Active ingredient: Roxatidini acetas hydrochloridum
Other information: prolonged-release tablet - 75 mg

Available in: Finland
Language: English
Source: Fimea

MELUSTON

MELUSTON

Marketed by: Aventis Pharma Deutschland GmbH
Active ingredient: Roxatidini acetas hydrochloridum
Other information: prolonged-release tablet - 150 mg

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: Aktiebolaget Draco
Active ingredient: Dimethylpolysiloxan
Other information: oral liquid - 10 mg/ml

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: AstraZeneca Oy
Active ingredient: Dimeticonum 1000,Silica colloidalis anhydrica
Other information: drops - 100 mg/ml

Available in: Finland
Language: English
Source: Fimea

MINIFOM

MINIFOM

Marketed by: GlaxoSmithKline AB
Active ingredient: Dimeticonum
Other information: capsule, soft - 200 mg

Available in: Finland
Language: English
Source: Fimea

METOPRAM

METOPRAM

Marketed by: Oy Leiras Finland Ab
Active ingredient: Metoclopramidi monohydrochloridum monohydricum
Other information: injection - 5 mg/ml

Available in: Finland
Language: English
Source: Fimea

METOPRAM

METOPRAM

Marketed by: Oy Leiras Finland Ab
Active ingredient: Metoclopramidi monohydrochloridum monohydricum
Other information: tablet - 10 mg

Available in: Finland
Language: English
Source: Fimea

METOPRAM

METOPRAM

Marketed by: Oy Leiras Finland Ab
Active ingredient: Metoclopramidi monohydrochloridum monohydricum
Other information: suppository - 20 mg

Available in: Finland
Language: English
Source: Fimea

METOPRAM

METOPRAM

Marketed by: Schering Oy
Active ingredient: Metoclopramidi monohydrochloridum monohydricum
Other information: oral liquid - 1 mg/ml

Available in: Finland
Language: English
Source: Fimea

METOPRAM

METOPRAM

Marketed by: Schering Oy
Active ingredient: Metoclopramidi monohydrochloridum monohydricum
Other information: injection - 10 mg/ml

Available in: Finland
Language: English
Source: Fimea

MIL-PAR

MIL-PAR

Marketed by: Seven Seas Limited
Active ingredient: Paraffinum liquidum,Magnesii hydroxidum
Other information: oral suspension

Available in: Finland
Language: English
Source: Fimea

METALAX

METALAX

Marketed by: Oy Leiras Finland Ab
Active ingredient: Bisacodylum
Other information: suppository - 10 mg

Available in: Finland
Language: English
Source: Fimea

METALAX

METALAX

Marketed by: Oy Leiras Finland Ab
Active ingredient: Bisacodylum
Other information: gastro-resistant tablet - 5 mg

Available in: Finland
Language: English
Source: Fimea

METALAX PEDIATRIC

METALAX PEDIATRIC

Marketed by: Oy Leiras Finland Ab
Active ingredient: Bisacodylum
Other information: suppository - 5 mg

Available in: Finland
Language: English
Source: Fimea